Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neoadjuvant multiagent chemotherapy or upfront surgery for primary resectable pancreatic cancer - A retrospective intention-to-treat analysis.

HPB : the official journal of the International Hepato Pancreato Biliary Association·2026
Same author

Efficacy of an XPO1 inhibitor in combination with irinotecan in a preclinical colorectal cancer model.

Frontiers in oncology·2026
Same author

Cholate Clearance: Improving the Assessment of Liver Health Compared to Current Liver Tests.

Gastro hep advances·2025
Same author

Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer.

Cancer research communications·2025
Same author

Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: an Academic Gastrointestinal Cancer Consortium Study.

The oncologist·2025
Same author

Pancreatic Cancer Progression Involves Increased Lysyl Oxidase-Mediated Collagen Cross-Links as Part of the Desmoplastic Reaction.

Biochemistry·2025

Related Experiment Video

Updated: Jun 20, 2026

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
07:59

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Published on: September 3, 2021

6.3K

Liver transplantation for colorectal cancer with liver metastases.

Benjamin E Ueberroth1, Michael Kriss2, James R Burton2

  • 1Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO 80045, United States.

The Oncologist
|January 21, 2025
PubMed
Summary

Liver transplantation offers a survival benefit for patients with colorectal cancer liver metastases. Careful patient selection and adherence to specific criteria improve outcomes, making it a viable option for advanced disease.

Keywords:
chemotherapycolon cancerliver transplantationmetastasisrectal cancer

More Related Videos

Application of Hemostatic Devices in Laparoscopic Hepatectomy
04:23

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Published on: April 19, 2022

2.2K
Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis
04:22

Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis

Published on: March 3, 2023

348

Related Experiment Videos

Last Updated: Jun 20, 2026

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
07:59

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Published on: September 3, 2021

6.3K
Application of Hemostatic Devices in Laparoscopic Hepatectomy
04:23

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Published on: April 19, 2022

2.2K
Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis
04:22

Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis

Published on: March 3, 2023

348

Area of Science:

  • Hepatobiliary Surgery
  • Surgical Oncology
  • Transplantation Medicine

Background:

  • Liver transplantation has shown survival benefits for colorectal cancer (CRC) with liver metastases.
  • Advances in organ preservation expand transplantation eligibility for unresectable liver metastases.
  • Current data indicate comparable overall survival (OS) to general liver transplant recipients.

Purpose of the Study:

  • To evaluate the efficacy of liver transplantation for unresectable colorectal cancer liver metastases.
  • To identify key criteria for patient selection and improved outcomes.
  • To support policy changes regarding organ allocation for this patient group.

Main Methods:

  • Review of clinical trials and available literature on liver transplantation for CRC liver metastases.
  • Analysis of factors predicting outcomes, including primary tumor resection, neoadjuvant chemotherapy, and restaging.
  • Assessment of specific criteria such as carcinoembryonic antigen (CEA) levels and tumor size.

Main Results:

  • Improved outcomes are associated with R0 resection, 6-12 months of neoadjuvant chemotherapy, and negative extrahepatic disease on imaging.
  • Chemotherapy response predicts long-term outcomes; progression is a contraindication.
  • CEA ≤80 µg/L and largest tumor <5.5 cm correlate with better progression-free and OS.

Conclusions:

  • Liver transplantation provides superior progression-free and OS compared to chemotherapy alone for select CRC liver metastases patients.
  • Rigorous patient selection using imaging, laboratory, and clinical data is crucial.
  • Liver transplantation should be considered at active transplant centers for advanced CRC.